Arabian Journal of Chemistry · 2016 · 17 citations · 29 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsCytotoxic ChemotherapyStructure-activity Relationship AnalysisTopoisomerase InhibitorsAnticancer ChemotherapyAssayBiological Evaluation ReportCytotoxicity AssaysStarting SystemsTopoisomerase I Inhibitors
Several 9-chloro-11H-indeno[1,2-c]quinolin-11-one derivatives have been designed which is replacing side chains with different groups containing oxygen, nitrogen or sulfur atoms. Substitution of C-6 on the starting structure, 6,9-dichloro-11H-indeno[1,2-c]quinolin-11-one, using apposite nucleophilic group with a suitable base or acid could be obtained 28 novel tetracyclic azafluorenone derivatives. The cytotoxic activity of these analogues was examined in cancer cell lines by MTT assay and compounds 4, 5, 13, and 26 were selected to evaluate in topoisomerase I drug screening assay, respectively. At the same time, 17 compounds were selected for NCI-60 anticancer drug screen to prevent the narrower concept of an in vitro screening model. Its worth to find that 9-chloro-6-(piperazin-1-yl)-11H-indeno[1,2-c]quinolin-11-one (12) showed greater cytotoxicity than another azafluorenone derivatives with an average GI50 of 10.498 μM over 60 cell lines. We also found that another analogue, 9-chloro-6-(2-methylpiperazin-1-yl)-11H-indeno[1,2-c]quinolin-11-one (13), exhibited preferential growth inhibition effect toward cancer cell lines and showed a significant inhibitory effect on topoisomerase I. Keywords: Indenoquinolinone, Topoisomerase I, Azafluorenone, Cytotoxicity, NCI-60 anticancer drug screen
29
Rapid colorimetric assay for cell growth and survival
François Denizot, Rita Lang · Journal of Immunological Methods · 1986 · 4.9K citations
A Model for the Mechanism of Human Topoisomerase I
Lance Stewart, Matthew R. Redinbo, Xiayang Qiu et al. · Science · 1998 · 703 citations
The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets.
Anne Monks, Scudiero Da, Johnson Gs et al. · PubMed · 1997 · 172 citations